POV p17 GettyImages 1396801907 ScientistTransparentScreen e1751398046719

The Impact of FDA’s Animal Use Shift on the Future of Preclinical Testing

Tech

Traditional and new laboratory tools along with advances in AI are outlining a new paradigm in human disease modeling. Don’t miss this July issue Point of View by Thomas Hartung, MD, PhD , Director, Center for Alternatives to Animal Testing (CAAT).The post The Impact of FDA’s Animal Use Shift on the Future of Preclinical Testing appeared first on GEN – Genetic Engineering and Biotechnology News.